HighPoint Advisor Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,529
Closed -$317K 1052
2025
Q4
$317K Buy
3,529
+510
+17% +$48.4K 0.01% 823
2025
Q3
$297K Buy
+3,019
New +$299K 0.01% 539
2024
Q2
Sell
-2,017
Closed -$241K 640
2024
Q1
$241K Sell
2,017
-303
-13% -$37.8K 0.02% 535
2023
Q4
$297K Buy
+2,320
New +$259K 0.02% 472
2021
Q3
$229K Sell
1,615
-480
-23% -$70.6K 0.02% 473
2021
Q2
$327K Buy
2,095
+196
+10% +$31.7K 0.03% 383
2021
Q1
$312K Buy
1,899
+8
+0.4% +$1.24K 0.04% 362
2020
Q4
$292K Buy
1,891
+171
+10% +$24.2K 0.04% 356
2020
Q3
$233K Buy
+1,720
New +$225K 0.04% 322
2020
Q1
Sell
-1,618
Closed -$234K 404
2019
Q4
$234K Hold
1,618
0.05% 307
2019
Q3
$226K Sell
1,618
-5
-0.3% -$646 0.05% 293
2019
Q2
$193K Buy
+1,623
New +$190K 0.05% 315
2018
Q4
Sell
-1,677
Closed -$202K 360
2018
Q3
$202K Buy
+1,677
New +$199K 0.06% 299
2018
Q2
Sell
-2,037
Closed -$226K 347
2018
Q1
$226K Buy
2,037
+161
+9% +$18.7K 0.06% 287
2017
Q4
$211K Sell
1,876
-38
-2% -$4.3K 0.06% 271
2017
Q3
$209K Sell
1,914
-16
-0.8% -$1.85K 0.06% 259
2017
Q2
$221K Hold
1,930
0.07% 254
2017
Q1
$221K Buy
+1,930
New +$219K 0.07% 254
2016
Q3
Sell
-1,777
Closed -$230K 320
2016
Q2
$230K Buy
+1,777
New +$201K 0.08% 239
2015
Q4
Sell
-8,016
Closed -$731K 215
2015
Q3
$731K Sell
8,016
-2,403
-23% -$241K 0.81% 47
2015
Q2
$1.1M Buy
+10,419
New +$1.15M 1.71% 23

Other funds holding ZBH

HighPoint Advisor Group's ZBH Position: Q1 2026 in Review

HighPoint Advisor Group sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 3,529 shares — an estimated $317K sold.

HighPoint Advisor Group first reported a position in ZBH in Q2 2015 and held it in 21 quarters. The position peaked at $1.1M in Q2 2015. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • HighPoint Advisor Group reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • HighPoint Advisor Group sold 3,529 Zimmer Biomet shares in Q1 2026, an estimated $317K.
  • HighPoint Advisor Group first reported a position in Zimmer Biomet in Q2 2015 and held it in 21 quarters.
  • HighPoint Advisor Group's Zimmer Biomet position peaked at $1.1M in Q2 2015.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.